Immunotherapy: reshape the tumor immune microenvironment
B Lv, Y Wang, D Ma, W Cheng, J Liu, T Yong… - Frontiers in …, 2022 - frontiersin.org
Tumor immune microenvironment (TIME) include tumor cells, immune cells, cytokines, etc.
The interactions between these components, which are divided into anti-tumor and pro …
The interactions between these components, which are divided into anti-tumor and pro …
Shaping polarization of tumor-associated macrophages in cancer immunotherapy
J Gao, Y Liang, L Wang - Frontiers in immunology, 2022 - frontiersin.org
Different stimuli can polarize macrophages into two basic types, M1 and M2. Tumor-
associated macrophages (TAMs) in the tumor microenvironment (TME) are composed of …
associated macrophages (TAMs) in the tumor microenvironment (TME) are composed of …
d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma
S Han, X Bao, Y Zou, L Wang, Y Li, L Yang, A Liao… - Science …, 2023 - science.org
The polarization of tumor-associated macrophages (TAMs) from M2 to M1 phenotype
demonstrates great potential for remodeling the immunosuppressive tumor …
demonstrates great potential for remodeling the immunosuppressive tumor …
Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment
The immunosuppressive status of the tumor microenvironment (TME) remains poorly
defined due to a lack of understanding regarding the function of tumor-associated …
defined due to a lack of understanding regarding the function of tumor-associated …
Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: the horizons in cancer treatment
S Gao, X Yang, J Xu, N Qiu, G Zhai - ACS nano, 2021 - ACS Publications
Immunotherapy that harnesses the human immune system to fight cancer has received
widespread attention and become a mainstream strategy for cancer treatment. Cancer …
widespread attention and become a mainstream strategy for cancer treatment. Cancer …
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …
Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
Y Zheng, Y Han, Q Sun, Z Li - Exploration, 2022 - Wiley Online Library
Reprogramming the immunosuppressive tumor microenvironment by modulating
macrophages holds great promise in tumor immunotherapy. As a class of professional …
macrophages holds great promise in tumor immunotherapy. As a class of professional …
Tumor-associated macrophages in pancreatic ductal adenocarcinoma: origin, polarization, function, and reprogramming
S Yang, Q Liu, Q Liao - Frontiers in cell and developmental biology, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy. PDAC is only
cured by surgical resection in its early stage, but there remains a relatively high possibility of …
cured by surgical resection in its early stage, but there remains a relatively high possibility of …
A virus‐mimicking nucleic acid nanogel reprograms microglia and macrophages for glioblastoma therapy
X Gao, S Li, F Ding, X Liu, Y Wu, J Li, J Feng… - Advanced …, 2021 - Wiley Online Library
Immunotherapy is recognized as one of the most promising approaches to treat cancers.
However, its effect in glioblastoma (GBM) treatment is insufficient, which can in part be …
However, its effect in glioblastoma (GBM) treatment is insufficient, which can in part be …
Peptide-drug conjugates: a new hope for cancer management
Cancer remains the leading cause of death worldwide despite advances in treatment
options for patients. As such, safe and effective therapeutics are required. Short peptides …
options for patients. As such, safe and effective therapeutics are required. Short peptides …